Beyond ischemic stroke, natural antioxidative compounds that regulate the GSK-3β/HO-1 signaling pathway may hold significant potential in the treatment of aging-related neurodegenerative diseases. The gene discussed is GSK3B; the disease is neurodegenerative disease.